1Russell JA. Management of sepsis[J]. N Engl J Med, 2006, 355 (21): 1699-1713.
2Dellinger RP, Levy MM, Carlet JM, et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2008 [J]. Intensive Care Med, 2008, 34(1): 17-60.
3Vincent JL. Clinical sepsis and septic shock-definition, diagnosis and management principles [J ]. Langenbeck's Archives Surg, 2008, 393(6): 817-824.
4Raghavan M, Marik PE. Management of sepsis during the early "golden hours"[J]. J Emerg Med, 2006, 31(2): 185-199.
5Morimatsu H, Singh K, Uchino S, et al. Early and exclusive use of norepinephrine in septic shock [J]. Resuscitation, 2004, 62 (2): 249-254.
6Russell JA, Walley KR, Singer J, et al. Vasopressin versus norepinephrine infusion in patients with septic shock [J]. N Engl J Med, 2008, 358(9): 877-887.
6Dellinger RP, Levy MM, Cadet JM, et al. Surviving sepsis campaign:international guidelines for management of severe sepsis and septic shock: 2008. Intensive Care Med, 2008,34 ( 1 ) : 17-60.
7Russell JA. Management of sepsis. N Engl J Med, 2006,355 (16) : 1699-1713.
8Nguyen HB, Loomba M, Yang JJ, et al. Early lactate clearance is associated with biomarkers of inflammation,coagulation, apoptosis,organ dysfunction and mortality in severe sepsis and septic shock. J Inflamm (Lord), 2010,7 : 6.
9Russell JA, Walley KR, Singer J, et al. Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med, 2008,358(9) : 877-887.
10Durairaj L, Schmidt GA. Fluid therapy in resuscitated sepsis: less is more. Chest, 2008,133(1) :252-263.
